Pleurisy Market Research Report-Forecast till 2027

Pleurisy Market Information: By Diagnosis Devices (Thoracentesis, Video-Assisted Thoracic Surgery, Blood Test), By Treatment (Antibiotics, Antifungals, Blood Thinners), By End User (Hospital, Clinics, Diagnostics Laboratories) -Forecast till 2027

ID: MRFR/MED/1179-HCR | February 2021 | Region: Global | 90 pages

Pleurisy Market Scenario


Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss.

Pneumonia, pulmonary embolism, autoimmune disorder, lung cancer, heart surgery, pancreatitis, chest trauma, and asbestosis are the diseases which cause pleurisy, thus, rising in population affected with these disease are the leading factor for the growth of global pleurisy market.

According to a report published by the World Cancer Research Fund International, in 2015, about 58% of lung cancer cases occurred in the developing countries. In a similar report by Centers for Disease Control and Prevention (CDC), in 2017, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States.

There are various causes responsible for this condition, such as rising aging population, unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of lung cancer; more than 60% of the global population smokes, this has increased the risk of lung cancer and contributed to the growth of the market.

Moreover, advancing technology in medical devices is adding fuel to the growth of the market. Furthermore, increasing government support for the developing countries also drives the market growth.

However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.

The pleurisy global market is expected to grow at a CAGR of 6.2% during the forecast period 2017-2023. 


Figure: Global Pleurisy Market, By Region Market Share, 2016 (%) Pleurisy Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The pleurisy global market is segmented on the basis of diagnosis devices, treatment, and by end user.


On the basis of the diagnosis devices, it is segmented into thoracentesis, video-assisted thoracic surgery, imaging devices, blood test, and others. Furthermore, imaging devices are segmented as computed tomography, magnetic resonance imaging, ultrasound, and others.


On the basis of the treatment, it is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others.  


On the basis of end user, it is segmented into hospital, clinics, diagnostics laboratories, and others.


Regional Analysis


The Americas dominate the global pleurisy market owing to the rising prevalence of disease such as autoimmune disorders, lung cancer, heart surgery, pancreatitis, chest trauma. Furthermore increasing government support for research & development and high healthcare spending have fuelled the growth of the market in this region. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 215,951 people in the United States were diagnosed with lung cancer, including 113,326 men and 102,625 women. Also around 155,526 people in the United States died from lung cancer, including 84,859 men and 70,667 women.

Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.

Asia Pacific is the fastest growing pleurisy market owing to the high presence of patient with chronic disease. Although rapidly developing healthcare technology, increasing demand for new treatment methods in countries like India and China is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare provide the opportunity for the market players to fill the gap between demand and supply and maximize the profits.

On the other hand, in the Middle East and Africa, hold the least market due to low research and development activities and poor healthcare infrastructure.

Key Players


Some of the key players in this market are: Scanlan International, Inc. (U.S.), Sontec Instruments (U.S.), Pilling Surgical Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Olympus Corporation (Japan), Delacroix-Chevalier (France), Myra & Co. (India), Wexler Surgical (Texas) and others.


Research Methodology Global Pleurisy Market


Sources: Annual reports, Press release, White paper, and Company presentation


 Intended Audience



  • Medical Devices Manufacturers

  • Government Research Laboratories

  • Research and Development (R&D) Companies

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories



Report Scope:
Report Attribute/Metric Details
  Market Size   2027:Significant value
  CAGR   6.2%
  Base Year   2017
  Forecast Period   2027
  Historical Data   2016
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis devices, Treatment and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Scanlan International, Inc. (U.S.), Sontec Instruments (U.S.), Pilling Surgical Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Olympus Corporation (Japan), Delacroix-Chevalier (France), Myra & Co. (India), Wexler Surgical (Texas)
  Key Market Opportunities   Quality Devices Manufacturer
  Key Market Drivers

  • Rising aging population
  • Unhealthy diet
  • Low physical activities


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    There is a membrane called pleura inside the chest cavity that surrounds the lungs. Any type of inflammation in it is known as pleurisy.

    Pleurisy market CAGR during the forecast period would be 6.2% during the forecast period.

    Pleurisy market players are Scanlan International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Sontec Instruments (U.S.), Delacroix-Chevalier (France), Olympus Corporation (Japan), Wexler Surgical (Texas), Myra & Co. (India), Pilling Surgical Inc. (U.S.), and others.

    The Americas would lead the global pleurisy market platform.

    The Asia Pacific would garner the maximum CAGR among all pleurisy market regions.

    Table of Content


    Report Prologue

    Market Introduction


    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations


    Research Methodology


    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation


    Market Dynamics


    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment


    Market Factor Analysis


    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis


    Global Pleurisy Market, by Diagnosis devices


    6.1 Introduction

    6.2 Thoracentesis

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Video-Assisted Thoracic Surgery

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Imaging Devices

    6.4.1 Market Estimates & Forecast, 2020-2027

    6.5 Blood Test

    6.5.1 Market Estimates & Forecast, 2020-2027

    6.6 Others

    6.6.1 Market Estimates & Forecast, 2020-2027


    Global Pleurisy Market, by Treatment


    7.1 Introduction

    7.2 Antibiotics

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Antifungals

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Blood thinners

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Nonsteroidal anti-inflammatory drugs

    7.5.1 Market Estimates & Forecast, 2020-2027

    7.6 Others

    7.6.1 Market Estimates & Forecast, 2020-2027


    Global Pleurisy Market, by End User


    8.1 Introduction

    8.2 Hospital

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Clinics

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Diagnostics Laboratories

    8.4.1 Market Estimates & Forecast, 2020-2027

    8.5 Others

    8.5.1 Market Estimates & Forecast, 2020-2027


    Global Pleurisy Market, by Region


    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 U.K

    9.3.1.4 Italy

    9.3.1.5 Spain

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    11 Company Profiles

    11.1 Scanlan International, Inc.

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Sontec Instruments

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Pilling Surgical Inc.

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Integra LifeSciences Corporation

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Olympus Corporation

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.6 Delacroix-Chevalier

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 Myra & Co.

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Wexler Surgical

    11.8.1 Overview

    11.8.2 Product Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Others

    12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Pharmaceutical Industry

    13 Appendix


    LIST OF TABLES

    Table 1 Pleurisy Industry Synopsis, 2020-2027

    Table 2 Global Pleurisy Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Pleurisy Market by Region, 2020-2027, (USD Million)

    Table 4 Global Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 5 Global Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 6 Global Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 7 North America Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 8 North America Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 9 North America Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 10 US Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 11 US Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 12 US Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 13 Canada Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 14 Canada Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 15 Canada Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 16 South America Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 17 South America Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 18 South America Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 19 Europe Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 20 Europe Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 21 Europe Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 22 Western Europe Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 23 Western Europe Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 24 Western Europe Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 25 Eastern Europe Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 26 Eastern Europe Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 27 Eastern Europe Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 28 Asia Pacific Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 29 Asia Pacific Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 30 Asia Pacific Pleurisy Market by End Users, 2020-2027, (USD Million)

    Table 31 Middle East & Africa Pleurisy Market by Diagnosis devices, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Pleurisy Market by Treatment, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Pleurisy Market by End Users, 2020-2027, (USD Million)




    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Pleurisy Market

    Figure 3 Segmentation Market Dynamics for Pleurisy Market

    Figure 4 Global Pleurisy Market Share, by Diagnosis devices 2020

    Figure 5 Global Pleurisy Market Share, by Treatment 2020

    Figure 6 Global Pleurisy Market Share, by End Users, 2020

    Figure 7 Global Pleurisy Market Share, by Region, 2020

    Figure 8 America Pleurisy Market Share, by Country, 2020

    Figure 9 Europe Pleurisy Market Share, by Country, 2020

    Figure 10 Asia Pacific Pleurisy Market Share, by Country, 2020

    Figure 11 Middle East & Africa Pleurisy Market Share, by Country, 2020

    Figure 12 Global Pleurisy Market: Company Share Analysis, 2020 (%)

    Figure 13 Scanlan International, Inc.: Key Financials

    Figure 14 Scanlan International, Inc.: Segmental Revenue

    Figure 15 Scanlan International, Inc.: Geographical Revenue

    Figure 16 Sontec Instruments: Key Financials

    Figure 17 Sontec Instruments: Segmental Revenue

    Figure 18 Sontec Instruments: Geographical Revenue

    Figure 19 Pilling Surgical: Key Financials

    Figure 20 Pilling Surgical: Segmental Revenue

    Figure 21 Pilling Surgical: Geographical Revenue

    Figure 22 Integra LifeSciences Corporation: Key Financials

    Figure 23 Integra LifeSciences Corporation: Segmental Revenue

    Figure 24 Integra LifeSciences Corporation: Geographical Revenue

    Figure 25 Olympus Corporation: Key Financials

    Figure 26 Olympus Corporation: Segmental Revenue

    Figure 27 Olympus Corporation: Geographical Revenue

    Figure 28 Delacroix-Chevalier: Key Financials

    Figure 29 Delacroix-Chevalier: Segmental Revenue

    Figure 30 Delacroix-Chevalier: Geographical Revenue

    Figure 31 Myra & Co.: Key Financials

    Figure 32 Myra & Co.: Segmental Revenue

    Figure 33 Myra & Co.: Geographical Revenue